SCHEMBL14959161

SCHEMBL14959161

CC1CCc2ccc(F)c(F)c2C1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP2A6 P11509 2/20 0.33
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
CYP2A13 Q16696 1/20 0.33
TSHR P16473 1/20 0.33
HTR2B P41595 1/20 0.33
TRPV1 Q8NER1 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
DRD2 P14416 2/20 0.32
DRD3 P35462 2/20 0.32
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14525551 0.85 DRD2 (0.42) HTR1DHTR1BALDH1A1CYP2A6CYP2A13
SCHEMBL16233583 0.78 DRD2 (0.50) TRPV1DRD2DRD3
SCHEMBL15684620 0.77 CYP1A2 (0.39) HTR1DHTR1BHTR2AHTR2CHTR2B
SCHEMBL14525553 0.76 DRD2 (0.34) HTR1DHTR1BCHRNB2CHRNB4CHRNA3
SCHEMBL6401741 0.75 HTR1D (0.38) HTR1DHTR1BALDH1A1TSHRDRD2
SCHEMBL21096538 0.74 CYP2A6 (0.33) ALDH1A1CYP2A6CYP2A13TSHRTRPV1
SCHEMBL31037 0.73 CYP2A6 (0.39) ALDH1A1KDM4ECYP2A6CYP2A13TSHR
SCHEMBL21891623 0.73 CYP2A6 (0.39) ALDH1A1KDM4ECYP2A6CYP2A13TSHR
SCHEMBL15684597 0.73
SCHEMBL15684658 0.72 HTR1D (0.36) HTR1DHTR1BTSHRDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150203756-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2015-07-23 US disclosed
US-20150203756-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2015-07-23 US disclosed
EP-2212308-B1 BENZO[F]CHROME AND PYRANO[3,2-F]CHROME DERIVATIVES FOR USE IN LIQUID CRYSTAL MEDIA MERCK PATENT GMBH (DE) 2013-05-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203756-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA SP1, FOXM1, S100A11 HTR1D 1012/4885HTR1B 722/4885ALDH1A1 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.